Suppr超能文献

丙型肝炎病毒包膜在人类中的进化加速与急性感染向慢性感染转变过程中体液免疫选择的进展一致。

Acceleration of hepatitis C virus envelope evolution in humans is consistent with progressive humoral immune selection during the transition from acute to chronic infection.

机构信息

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, 855 N. Wolfe St., suite 530, Baltimore, MD 21205, USA.

出版信息

J Virol. 2010 May;84(10):5067-77. doi: 10.1128/JVI.02265-09. Epub 2010 Mar 3.

Abstract

During the transition from acute to chronic infection in individuals persistently infected with hepatitis C virus (HCV), cellular responses initiate within the first 6 months of primary infection and collapse thereafter, whereas humoral responses activate later during the chronic phase. Whether and how this deviation of immune responses specifically influences HCV evolution are unknown. To determine the pattern of HCV evolution during this critical period, we conducted extensive sequence analysis on annual clonal hemigenomic sequences for up to 3 years in six well-characterized subjects, using statistical methods that accounted for repeated measures. Significantly different evolutionary rates were observed in envelope versus nonenvelope genes, with an increasing rate of nonsynonymous change (dN) in envelope genes and a stable dN in nonenvelope genes (P = 0.006). The ratio of the envelope to nonenvelope nonsynonymous rate increased from 2 in year 1 to 5 in years 2 and 3. Centripetal changes (reversions toward matching of the worldwide subtype 1a consensus sequence) were frequently observed during the 3-year transition from acute infection to chronicity, even in the presence of neutralizing antibody (NAb) pressure. Remarkably, sequences of hypervariable region 1 (HVR1) remained stable for up to 21 months in the absence of NAb pressure in one subject, followed by rapid changes that were temporally associated with the detection of NAb responses, which strongly suggests that HVR1 evolution is shaped by NAb pressure. These data provide the first systematic estimates of HCV evolutionary rates in multiple genes during early infection in vivo and provide additional evidence for deterministic, rather than random, evolution of HCV.

摘要

在慢性丙型肝炎病毒(HCV)感染者从急性感染向慢性感染的转变过程中,细胞免疫反应在初次感染的前 6 个月内启动,此后便崩溃,而体液免疫反应则在慢性期晚期激活。这种免疫反应的偏差是否以及如何具体影响 HCV 的进化尚不清楚。为了确定在这一关键时期 HCV 进化的模式,我们对六名特征明确的研究对象进行了长达 3 年的每年一次的克隆半基因组序列的广泛序列分析,采用了考虑重复测量的统计方法。包膜基因与非包膜基因的进化速率明显不同,包膜基因的非同义突变率(dN)呈递增趋势,而非包膜基因的 dN 则保持稳定(P = 0.006)。包膜基因与非包膜基因的非同义率比值从第 1 年的 2 增加到第 2 年和第 3 年的 5。在从急性感染向慢性感染的 3 年转变过程中,即使存在中和抗体(NAb)压力,也经常观察到向全球 1a 亚型共识序列趋同的中心性变化(回复突变)。值得注意的是,在一个没有 NAb 压力的研究对象中,HVR1 序列在长达 21 个月的时间内保持稳定,随后迅速发生变化,与 NAb 反应的检测时间相关,这强烈表明 HVR1 的进化受到 NAb 压力的影响。这些数据首次提供了 HCV 在体内早期感染多个基因的进化速率的系统估计,并为 HCV 的确定性进化而非随机进化提供了额外的证据。

相似文献

9
Humoral immune response in acute hepatitis C virus infection.急性丙型肝炎病毒感染中的体液免疫反应。
Clin Infect Dis. 2005 Sep 1;41(5):667-75. doi: 10.1086/432478. Epub 2005 Jul 22.
10
Direct-acting antivirals for chronic hepatitis C.用于慢性丙型肝炎的直接作用抗病毒药物。
Cochrane Database Syst Rev. 2017 Sep 18;9(9):CD012143. doi: 10.1002/14651858.CD012143.pub3.

引用本文的文献

6
Mechanisms of HCV resistance to broadly neutralizing antibodies.HCV 对广泛中和抗体耐药的机制。
Curr Opin Virol. 2021 Oct;50:23-29. doi: 10.1016/j.coviro.2021.07.003. Epub 2021 Jul 28.
9
Hepatitis C Virus Vaccine: Challenges and Prospects.丙型肝炎病毒疫苗:挑战与前景
Vaccines (Basel). 2020 Feb 17;8(1):90. doi: 10.3390/vaccines8010090.
10
Challenges and Promise of a Hepatitis C Virus Vaccine.丙型肝炎病毒疫苗的挑战与前景。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a036947. doi: 10.1101/cshperspect.a036947.

本文引用的文献

6
Acute hepatitis C.急性丙型肝炎
Lancet. 2008 Jul 26;372(9635):321-32. doi: 10.1016/S0140-6736(08)61116-2.
7
Hepatitis C virus entry and neutralization.丙型肝炎病毒的进入与中和
Clin Liver Dis. 2008 Aug;12(3):693-712, x. doi: 10.1016/j.cld.2008.03.008.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验